Executive Management

With approximately 30 years of pharmaceutical industry experience, Tim is a founding officer and the current President of RMC Pharmaceutical Solutions Incorporated (RMC). This experience extends across several pharma organizations ranging from large global operations (American Home Products/Wyeth-Ayerst) and mid-size development programs (Amylin Pharmaceuticals), to early-stage/startup companies (FeRx Incorporated and RMC). This uniquely diverse background, includes direct experience spanning the entire GxP (i.e. GLP, GMP and GCP) spectrum of activities that support the pre-clinical/clinical research, CMC/product development and commercialization of regulated drug and device products. This background is not only an asset in the executive team's management of RMC's corporate development and sustained growth, but it has also been vital in allowing Tim to serve RMC clients as a Principal Consultant.

Scott is a founding member of RMC Pharmaceutical Solutions, and currently serves as its technical leader. Scott brings 14 years experience in the pharmaceutical industry, and an additional seven years of academic and government sponsored research and development in bioprocessing to the RMC Pharmaceutical Solutions team. Scott received his PhD in chemical engineering from Purdue University in 1989. He is an adjunct professor of chemical engineering at the University of Colorado, a guest researcher at the National Institute of Standards and Technology, and co-author of a leading text book on bioseparations. Scott has also worked at Amylin Pharmaceuticals Incorporated, Synergen Incorporated, and the National Institute of Standards and Technology. In addition to his role as chief technical officer, Scott assists clients as a Principal Consultant.